Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin

J Neurol. 2013 May;260(5):1406-7. doi: 10.1007/s00415-013-6866-6. Epub 2013 Feb 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Brain / pathology
  • Cisplatin / therapeutic use
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Female
  • Gemcitabine
  • Humans
  • Immunologic Factors / therapeutic use*
  • Magnetic Resonance Imaging
  • Posterior Leukoencephalopathy Syndrome / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Deoxycytidine
  • Bevacizumab
  • Cisplatin
  • Gemcitabine